The DOI matches its Crossref record.
The Effect of Biofeedback Physical Therapy in Men with Chronic Pelvic Pain Syndrome Type III
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The largest of the three studies, which evaluated the effect of six to eight biofeedback sessions, showed a mean reduction in the total NIH‐CPSI score from 23.6 at baseline to 11.4 after treatment (P < 0.001) 88.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [88]
In the citing paper
“Three small (n = 19–31) pilot studies 87, 88, 89 have shown that a pelvic floor biofeedback re‐educating programme significantly reduces symptom severity in patients with CP/CPPS.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 14
- Schaeffer, 2002, Classification (traditional and national institutes of health) and demographics of prostatitis, Urology, 60, 5, 10.1016/S0090-4295(02)02292-6 · doi:10.1016/s0090-4295(02)02292-6
- Roberts, 2002, Prevalence of prostatitis-like symptoms in a community based cohort of older men, J Urol, 168, 2467, 10.1016/S0022-5347(05)64170-5 · DOI
- Litwin, 2002, A review of the development and validation of the national institutes of health chronic prostatitis symptom index, Urology, 60, 14, 10.1016/S0090-4295(02)02296-3 · DOI
- Turner, 2003, Validity and responsiveness of the national institutes of health chronic prostatitis symptom index, J. Urol, 169, 580, 10.1016/S0022-5347(05)63957-2 · DOI
- Curtis Nickel, 1999, Prostatitis: Evolving management strategies, Urological Clinics of North America, 26, 737, 10.1016/S0094-0143(05)70215-9 · doi:10.1016/s0094-0143(05)70215-9
- Kieger, 2002, Chronic prostatitis: epidemiology and role of infection, Urology, 60, 8, 10.1016/S0090-4295(02)02294-X · doi:10.1016/s0090-4295(02)02294-x
- Lee, 2003, Prostate biopsy cultures findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls, J Urol, 169, 584, 10.1016/S0022-5347(05)63958-4 · DOI
- Yeong Cheah, 2003, Terazosin therapy for chronic prostatits/chronic pelvic pain syndrome: a randomized placebo controlled trail, J Urol, 169, 592, 10.1016/S0022-5347(05)63960-2 · doi:10.1016/s0022-5347(05)63960-2
- Mehik, 2003, Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study, Urology, 62, 425, 10.1016/S0090-4295(03)00466-7 · DOI · Paper page
- Segura, 1979, Prostatosis, prostatitis or pelvic floor tension myalgia?, J Urol, 122, 168, 10.1016/S0022-5347(17)56309-0 · DOI
- Zermann, 1999, Neurological insights into the etiology of genitourinary pain in men, J Urol, 161, 903, 10.1016/S0022-5347(01)61802-0 · DOI
- Hetrick, 2003, Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case control study, J Urol, 170, 828, 10.1097/01.ju.0000080513.13968.56 · DOI · Paper page
- Clemens, 2000, Biofeedback, pelvic floor re-education, and bladder training for male pelvic pain syndrome, Urology, 56, 951, 10.1016/S0090-4295(00)00796-2 · DOI · Paper page
- Roehrborn, 2001, Alfuzosin: overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alpha-blocker, Urology, 58, 55, 10.1016/S0090-4295(01)01322-X · doi:10.1016/s0090-4295(01)01322-x
Cited by
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
FitzGerald, M. P., Anderson, R. U., Potts, J., Payne, C. K., Peters, K. M., Clemens, J. Q., Kotarinos, R., Fraser, L., Cosby, A., Fortman, C., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.11.018 · Cited by 274
FitzGerald, M. P., Payne, C. K., Lukacz, E. S., Yang, C. C., Peters, K. M., Chai, T. C., Nickel, J. C., Hanno, P. M., Kreder, K. J., Burks, D. A., et al. (2012) · Journal of Urology · doi:10.1016/j.juro.2012.01.123 · Cited by 266
Abbott, J. A., Jarvis, S. K., Lyons, S. D., Thomson, A., & Vancaille, T. G. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000237100.29870.cc · Cited by 255
Rosenbaum, T. Y. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00393.x · Cited by 231
Metadata
- Authors
- Cornel, E. B., van Haarst, E. P., Schaarsberg, R. W. M. B.-G., & Geels, J.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 47
- Issue
- 5
- Pages
- 607-611
- ISSN
- 0302-2838
- Cited by
- 113
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Biofeedback Physical Therapy in Men with Chronic Pelvic Pain Syndrome Type III. https://app.cochat.ai/papers/10.1016/j.eururo.2004.12.014
- The paper
- Cornel, E. B., van Haarst, E. P., Schaarsberg, R. W. M. B.-G., & Geels, J. (2005). The Effect of Biofeedback Physical Therapy in Men with Chronic Pelvic Pain Syndrome Type III. European Urology. https://doi.org/10.1016/j.eururo.2004.12.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.